The Obese Brain—Effects of Bariatric Surgery on Energy Balance Neurocircuitry

Current Atherosclerosis Reports

Volumn 17, Issue 10, 2015, Pages

  de Lima Júnior, José Carlos ^a   Velloso, Lício A ^a   Geloneze, Bruno ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Bariatric surgery; Brain; Hypothalamus; Obesity; Roux en Y gastric bypass

Indexed keywords

AGOUTI RELATED PROTEIN; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; GLUCAGON LIKE PEPTIDE 1; INSULIN; LEPTIN; MELANOCORTIN; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; SATURATED FATTY ACID;

ARCUATE NUCLEUS; BARIATRIC SURGERY; BROWN ADIPOSE TISSUE; DIET INDUCED OBESITY; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD INTAKE; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; NONHUMAN; OBESITY; REVIEW; ROUX EN Y GASTRIC BYPASS; STOMACH BYPASS; THERMOGENESIS; WEIGHT REDUCTION; ANIMAL; BRAIN; ENERGY METABOLISM; METABOLISM; OBSERVATIONAL STUDY;

ANIMALS; BARIATRIC SURGERY; BRAIN; ENERGY METABOLISM; HUMANS; INSULIN RESISTANCE; OBESITY; OBSERVATIONAL STUDIES AS TOPIC;

EID: 84940174801     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-015-0536-3     Document Type: Review

References (79)

1. Myers Jr MG, Munzberg H, Leinninger GM, Leshan RL. The geometry of leptin action in the brain: more complicated than a simple ARC. Cell Metab. 2009;9:117–23.
2. Guyenet SJ, Schwartz MW. Clinical review: regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity. J Clin Endocrinol Metab. 2012;97:745–55.
3. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311:806–14.
4. Rillamas-Sun E et al. Obesity and late-age survival without major disease or disability in older women. JAMA Intern Med. 2014;174:98–106.
5. Arruda AP et al. Low-grade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion. Endocrinology. 2011;152:1314–26.
6. Thaler JP et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest. 2012;122:153–62. This study reinforces the evidence of hypothalamic injury in rodents and humans with important mechanistic statements.
7. Hankir MK, Ashrafian H, Hesse S, Horstmann A, Fenske WK. Distinctive striatal dopamine signaling after dieting and gastric bypass. Trends Endocrinol Metab. 2015;26:223–30.
8. Thaler JP, Guyenet SJ, Dorfman MD, Wisse BE, Schwartz MW. Hypothalamic inflammation: marker or mechanism of obesity pathogenesis? Diabetes. 2013;62:2629–34.
9. Ryan KK, Woods SC, Seeley RJ. Central nervous system mechanisms linking the consumption of palatable high-fat diets to the defense of greater adiposity. Cell Metab. 2012;15:137–49.
10. Bungo T et al. Intracerebroventricular administration of mouse leptin does not reduce food intake in the chicken. Brain Res. 1999;817:196–8.
11. Gautron L, Elmquist JK, Williams KW. Neural control of energy balance: translating circuits to therapies. Cell. 2015;161:133–45.
12. Schauer PR et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.
13. Warne JP, Xu AW. Metabolic transceivers: in tune with the central melanocortin system. Trends Endocrinol Metab. 2013;24:68–75.
14. Schwartz MW, Porte Jr D. Diabetes, obesity, and the brain. Science. 2005;307:375–9.
15. Schneeberger M, Gomis R, Claret M. Hypothalamic and brainstem neuronal circuits controlling homeostatic energy balance. J Endocrinol. 2014;220:T25–46.
16. Cone RD. Anatomy and regulation of the central melanocortin system. Nat Neurosci. 2005;8:571–8.
17. Haskell-Luevano C et al. Characterization of the neuroanatomical distribution of agouti-related protein immunoreactivity in the rhesus monkey and the rat. Endocrinology. 1999;140:1408–15.
18. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest. 2007;117:13–23.
19. Zhang Y et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–32.
20. Richard D. Cognitive and autonomic determinants of energy homeostasis in obesity. Nat Rev Endocrinol. 2015. doi:10.1038/nrendo.2015.103.
21. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404:661–71.
22. Xu H et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30.
23. Hoeg LD et al. Lipid-induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling. Diabetes. 2011;60:64–73.
24. Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15:635–45.
25. De Souza CT et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology. 2005;146:4192–9.
26. Wisse BE, Schwartz MW. Does hypothalamic inflammation cause obesity? Cell Metab. 2009;10:241–2.
27. Velloso LA, Schwartz MW. Altered hypothalamic function in diet-induced obesity. Int J Obes (Lond). 2011;35:1455–65.
28. Myers Jr MG, Leibel RL, Seeley RJ, Schwartz MW. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab. 2010;21:643–51.
29. Milanski M et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci. 2009;29:359–70.
30. Moraes JC et al. High-fat diet induces apoptosis of hypothalamic neurons. PLoS One. 2009;4:e5045.
31. Manning S, Pucci A, Batterham RL. Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms. J Clin Invest. 2015;125:939–48. Complete review of the effects of bariatric surgery on mesolimbic and nigrostriatal dopaminergic pathways, emphasizing its homology to the dissociated behavior of neuronal groups AgRP and POMC in the arcuate nucleus.
32. Matsuda M et al. Altered hypothalamic function in response to glucose ingestion in obese humans. Diabetes. 1999;48:1801–6.
33. Frank S et al. Altered brain activity in severely obese women may recover after Roux-en Y gastric bypass surgery. Int J Obes (Lond). 2014;38:341–8. This study adds evidence to a hypothalamic recovery after RYGB.
34. Rachid B et al. Distinct regulation of hypothalamic and brown/beige adipose tissue activities in human obesity. Int J Obes (Lond). 2015. This recent study adds negative evidence to the hypothalamic involvement in regulating the activation of brown adipose tissue after RYGB.
35. Morrison SF. 2010 Carl Ludwig distinguished lectureship of the APS neural control and autonomic regulation section: central neural pathways for thermoregulatory cold defense. J Appl Physiol. 1985;110:1137–49 (2011).
36. van de Sande-Lee S et al. Partial reversibility of hypothalamic dysfunction and changes in brain activity after body mass reduction in obese subjects. Diabetes. 2011;60:1699–704.
37. Vetter ML, Cardillo S, Rickels MR, Iqbal N. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med. 2009;150:94–103.
38. Bates SH et al. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature. 2003;421:856–9.
39. Niswender KD et al. Intracellular signalling. Key enzyme in leptin-induced anorexia Nature. 2001;413:794–5.
40. Thaler JP, Choi SJ, Schwartz MW, Wisse BE. Hypothalamic inflammation and energy homeostasis: resolving the paradox. Front Neuroendocrinol. 2010;31:79–84.
41. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332:621–8.
42. Cypess AM et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360:1509–17.
43. van Marken Lichtenbelt WD et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009;360:1500–8.
44. Wu J et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012;150:366–76.
45. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84:277–359.
46. Surwit RS et al. Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc Natl Acad Sci U S A. 1998;95:4061–5.
47. Morrison SF, Madden CJ, Tupone D. Central neural regulation of brown adipose tissue thermogenesis and energy expenditure. Cell Metab. 2014;19:741–56.
48. Morrison SF, Madden CJ. Central nervous system regulation of brown adipose tissue. Compr Physiol. 2014;4:1677–713.
49. Dodd GT et al. Leptin and insulin act on POMC neurons to promote the browning of white fat. Cell. 2015;160:88–104.
50. Paranjape SA et al. Improvement in hepatic insulin sensitivity after Roux-en-Y gastric bypass in a rat model of obesity is partially mediated via hypothalamic insulin action. Diabetologia. 2013;56:2055–8. This recent paper adds evidence to an improved insulin signaling in the hypothalamus after RYGB and their contribution to the energy balance.
51. Kullmann S, Heni M, Fritsche A, Preissl H. Insulin action in the human brain: evidence from neuroimaging studies. J Neuroendocrinol. 2015;27:419–23.
52. Lima MM et al. Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3871–5.
53. Shin AC, Berthoud HR. Obesity surgery: happy with less or eternally hungry? Trends Endocrinol Metab. 2013;24:101–8.
54. Lima MM et al. Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers. Obesity (Silver Spring). 2013;21(E182–9).
55. Maclean PS, Bergouignan A, Cornier MA, Jackman MR. Biology’s response to dieting: the impetus for weight regain. Am J Physiol Regul Integr Comp Physiol. 2011;301:R581–600.
56. Meguid MM, Glade MJ, Middleton FA. Weight regain after Roux-en-Y: a significant 20 % complication related to PYY. Nutrition. 2008;24:832–42.
57. Magro DO et al. Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg. 2008;18:648–51.
58. Enriori PJ et al. Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab. 2007;5:181–94.
59. Geloneze B et al. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes. Obes Surg. 2001;11:693–8.
60. Rosenbaum M et al. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest. 2005;115:3579–86.
61. Hao Z et al. Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery. Int J Obes (Lond). 2015;39:798–805.
62. Yu Y, Deng C, Huang XF. Obese reversal by a chronic energy restricted diet leaves an increased Arc NPY/AgRP, but no alteration in POMC/CART, mRNA expression in diet-induced obese mice. Behav Brain Res. 2009;205:50–6.
63. Romanova IV et al. Neurobiologic changes in the hypothalamus associated with weight loss after gastric bypass. J Am Coll Surg. 2004;199:887–95.
64. Korner J et al. Randomized double-blind placebo-controlled study of leptin administration after gastric bypass. Obesity (Silver Spring). 2013;21:951–6. This study adds evidence to the role of relative leptin insufficiency in defense of adiposity after RYGB.
65. Guijarro A et al. Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1474–89.
66. Morinigo R et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2006;91:1735–40.
67. Nannipieri M et al. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab. 2013;98:4391–9.
68. Clements RH, Gonzalez QH, Long CI, Wittert G, Laws HL. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus. Am Surg. 2004;70:1–4. Discussion 4-5.
69. Korner J et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond). 2009;33:786–95.
70. Dirksen C et al. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. Int J Obes (Lond). 2013;37:1452–9.
71. Borg CM et al. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg. 2006;93:210–5.
72. Pournaras DJ et al. The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study. Obes Surg. 2010;20:56–60.
73. Lutz TA, Bueter M. The physiology underlying roux-en-Y gastric bypass: a status report. Am J Physiol Regul Integr Comp Physiol. 2014;307:R1275–91.
74. Ye J et al. GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. Am J Physiol Regul Integr Comp Physiol. 2014;306:R352–62. This recent study astoundingly supply no involvement for GLP-1 receptor brain signaling in the mechanisms by which RYGB maintain a lower body weight.
75. Lockie SH et al. Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling. Diabetes. 2012;61:2753–62.
76. Abegg K, Schiesser M, Lutz TA, Bueter M. Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass. Physiol Behav. 2013;121:70–8.
77. Chandarana K et al. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. Diabetes. 2011;60:810–8.
78. Fang S et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat Med. 2015;21:159–65.
79. Keitel V et al. The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. Glia. 2010;58:1794–805.